{"id":3450,"date":"2019-01-15T12:36:46","date_gmt":"2019-01-15T17:36:46","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/id\/?page_id=3450"},"modified":"2026-04-01T09:34:30","modified_gmt":"2026-04-01T13:34:30","slug":"trainingprograms-bu-chart-bu-chart-current-trainees","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/id\/research-programs\/bu-chart\/trainingprograms-bu-chart-bu-chart-current-trainees\/","title":{"rendered":"BU-CHART Trainees"},"content":{"rendered":"

\"\"Christopher Chiu, PhD, MA<\/strong><\/h2>\n

Christopher Chiu, PhD, MA received his PhD and MA in Clinical Psychology from the University of Massachusetts Boston and his undergraduate degree in Psychology from the University of Rochester. He was a predoctoral and postdoctoral fellow in the Behavioral Medicine program at the Massachusetts General Hospital\/Harvard Medical School.<\/p>\n

During his graduate training, Chris was selected and awarded a competitive 4-year fellowship through the Health Policy Research Scholars program of the Robert Wood Johnson Foundation and received specialized training on translating research into health policy to promote health equity. Prior to joining the BU-CHART program, Chris also served as a project director on two clinical trials that aim to address the psychobehavioral needs of communities with HIV who are sub optimally engaged in care and who have challenges with substance use (R34 and R01, PI: Abby Batchelder). These experiences have shaped Chris\u2019 research interest and goals in addressing social determinants of health that drive health disparities among LGBTQIA+ communities of color.<\/p>\n

As a BU-CHART Trainee and Research Fellow, he will continue working within the Behavioral Health Equity program under the research mentorship of Drs. Abigail Batchelder, Allen Gifford, and Carl Streed. During his fellowship, he plans to conduct research that informs the development of status-neutral psychobehavioral interventions that address the mental health and subsistence needs of sexual minority men of color with and vulnerable to HIV.<\/p>\n

Mentors<\/span><\/strong><\/h4>\n

Abigail Batchelder, PhD, MPH<\/strong><\/a> \u2013 Director of the Behavioral Health Equity Program and Associate Vice Chair of Psychology, Department of Psychiatry\u00a0Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Allen Gifford, MD<\/a>\u00a0\u2013 <\/strong>Professor of Health Law, Policy & Management, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Carl Streed, MD, MPH<\/span><\/a> \u2013 <\/strong>Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/span><\/strong><\/h4>\n

Chiu C<\/strong>, Gnall K, Kaiser AP, Taft CT, Franz MR, Lee LO, Vasterling JJ. Neurocognitive Performance Predicts Future Partner Violence Among U.S. Iraq-and Afghanistan-deployed Army Soldiers and Veterans. Psychol Violence<\/a>. 2022 May;12(3):160-169. doi: 10.1037\/vio0000408. Epub 2022 Feb 14. PMID: 38463935; PMCID: PMC10923519.<\/span><\/p>\n

Pantalone DW, Nelson KM, Batchelder AW, Chiu C<\/strong>, Gunn HA, Horvath KJ. A Systematic Review and Meta-Analysis of Combination Behavioral Interventions Co-Targeting Psychosocial Syndemics and HIV-Related Health Behaviors for Sexual Minority Men<\/a>. J Sex Res. 2020 Jul;57(6):681-708. doi: 10.1080\/00224499.2020.1728514. Epub 2020 Feb 20. PMID: 32077326; PMCID: PMC7457381.<\/span><\/p>\n

DeGutis J, Chiu C<\/strong>, Thai M, Esterman M, Milberg W, McGlinchey R. Trauma Sequelae are Uniquely Associated with Components of Self-Reported Sleep Dysfunction in OEF\/OIF\/OND Veterans<\/a>. Behav Sleep Med. 2018 Jan-Feb;16(1):38-63. doi: 10.1080\/15402002.2016.1173550. Epub 2016 May 16. PMID: 27183394.<\/span><\/p>\n

D\u00e9j\u00e0 Clement, MS, MPH, PhD <\/strong><\/h2>\n

\"\"<\/p>\n

D\u00e9j\u00e0 Clement, PhD, MPH, MS received her PhD in Clinical Psychology, MPH with a specialty in Rural and Underserved Communities, and MS in Psychology with an emphasis in Behavioral Medicine\/Health Psychology from Oklahoma State University. She received her undergraduate degree in Psychology from West Virginia University, where she was also a Ronald E. McNair Scholar. She recently completed her clinical psychology residency at Massachusetts General Hospital\/Harvard Medical School in the Behavioral Medicine program.\u00a0<\/span><\/o:p><\/p>\n

D\u00e9j\u00e0 has received several competitively funded research fellowships, including the Fostering Diversity in HIV Research Fellowship at Harvard Medical School and Brigham Research in Infectious Diseases and Global Engagement Fellowship (BRIDGE) at Brigham and Women\u2019s Hospital. Recently, D\u00e9j\u00e0 was selected to be a research fellow in the Research Education Institute for Diverse Scholars (REIDS) within the Center for Interdisciplinary Research on AIDS (CIRA) at Yale University\u2019s School of Public Health.\u00a0<\/span><\/o:p><\/p>\n

Grounded in intersectionality theory and Black Feminist thought, D\u00e9j\u00e0\u2019s research program aims to combine psychological, public health, and community-informed perspectives to understand and intervene on psychosocial and contextual stressors, including systemic oppression, intersectional minority stress, and experiences of discrimination as they influence health outcomes (i.e., suicide, substance use, and HIV) and health behaviors for minoritized populations (i.e., Black women, women of color). Her current work focuses on developing and implementing adapted psycho-behavioral interventions to improve HIV treatment engagement in individuals at risk or with HIV and who use substances among Black women.\u00a0<\/span><\/o:p><\/p>\n

As a BU-CHART Trainee and Research Fellow, she will be working within the Behavioral Health Equity Program under the research mentorship of Dr. Abigail Batchelder, Dr. Sabrina Assoumou, and Dr. Alex Walley. She plans to conduct a study that understands and intervenes on the unique needs of Black women who use opioids and who have HIV\/ are at-risk for HIV through the development of a multi-level, culturally responsive, and trauma-informed psycho-behavioral intervention.\u00a0<\/span><\/o:p><\/p>\n

Outside of work, D\u00e9j\u00e0 enjoys cooking\/eating food, running, and spending time with her dog!\u00a0Follow D\u00e9j\u00e0 on LinkedIn<\/a> or X (Twitter)<\/a> for updates on her work! <\/span><\/o:p><\/p>\n

Mentors<\/span><\/strong><\/h4>\n

Abigail Batchelder, PhD, MPH<\/strong><\/a> \u2013\u00a0Director of the Behavioral Health Equity Program and Associate Vice Chair of Psychology, Department of Psychiatry\u00a0Boston University Chobanian & Avedisian School of Medicine<\/span><\/p>\n

Sabrina Assoumou, MD, MPH<\/a> \u2013 <\/strong>Inaugural Louis W. Sullivan, MD, Professor of Medicine and Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Alexander Walley, MD, MSc<\/span><\/a> \u2013<\/strong>Professor of Medicine and Director of Addiction Medicine Fellowship Program, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/span><\/strong><\/h4>\n

Clement DN<\/strong>, Appleseth HS, Armstrong C, Cole AB, Wingate LR, Leffingwell T. (2023). Minoritized Graduate Student Identity, Wellbeing, and Suicide Risk<\/a>. <\/em>Journal of Diversity in Higher Education. 2023. https:\/\/doi.org\/10.1037\/dhe0000555<\/span>.<\/p>\n

Clement DN<\/b>, Oliphant V, Awad S, Wingate LR. Race-Based Rejection Sensitivity and the Integrated <\/a>Motivational Volitional Model of Suicide in a Sample of Black Women.<\/i> Clinical Psychological Science. 2022. https:\/\/doi.org\/10.1177\/21677026221147265<\/span><\/span><\/o:p><\/p>\n

Oliphant V, Broyles D, Clement DN, <\/strong>Wingate L. Mental Health Strategies Informed by Black Feminist Thought<\/a>.\u00a0Open Cultural Studies<\/em>, 6(1), 137-146. 2022. https:\/\/doi.org\/10.1515\/culture-2022-0151<\/span><\/p>\n

Wiglesworth A, Clement DN<\/strong>, Wingate LR, Klimes-Dougan B. Understanding suicide risk for youth who are both Black and Native American: The role of intersectionality and multiple marginalization<\/a>. Suicide Life Threat Behav. 2022 Aug;52(4):668-682. doi: 10.1111\/sltb.12851. Epub 2022 Mar 8. PMID: 35258124.<\/span><\/o:p><\/p>\n

Clement DN<\/strong>, Wingate LR, Cole AB, O’Keefe VM, Hollingsworth DW, Davidson CL, Hirsch JK. The Common Factors of Grit, Hope, and Optimism Differentially Influence Suicide Resilience<\/a>. Int J Environ Res Public Health. 2020 Dec 21;17(24):9588. doi: 10.3390\/ijerph17249588. PMID: 33371423; PMCID: PMC7767414.<\/span><\/p>\n

Rebecca Fisk-Hoffman, PhD <\/strong><\/h2>\n

\"\"<\/p>\n

Rebecca Fisk-Hoffman, PhD completed her doctoral studies in epidemiology at the University of Florida. Her dissertation work focused on the implementation of long-acting injectable antiretroviral therapy for HIV treatment and interest in future long-acting HIV treatments and was supported by a Ruth L. Kirschstein Predoctoral Individual National Research Service Award from the National Institute on Alcohol Abuse and Alcoholism. She also worked on the Florida Cohort Study Wave 3, a large, multi-site study seeking to identify barriers to key steps in the HIV Care Continuum. Prior to that she received her MPH from the University of Texas Health Sciences Center in Houston.<\/p>\n

As a BU-CHART Fellow, she will be working with Dr. So-Armah on the Tuberculosis, Alcohol and Lung Comorbidities Study (TALC) which is assessing the impact of unhealthy alcohol use on the risk of developing post-TB lung disease among people with HIV (PWH) in southwestern Uganda. She will be working with the TALC team to develop and implement an alcohol reduction intervention for delivery in HIV\/TB care.<\/p>\n

Mentors<\/span><\/strong><\/h4>\n

Kaku So-Armah, PhD<\/strong><\/a> \u2013 Associate Professor of Medicine, General Internal Medicine,\u00a0Boston University Chobanian & Avedisian School of Medicine<\/span><\/p>\n

Mari-Lynn Drainoni, PhD<\/strong><\/a> \u2013 Research Professor of Medicine, Section of Infectious Diseases,\u00a0Boston University Chobanian & Avedisian School of Medicine<\/span><\/p>\n

Simeon Kimmel, MD, MA <\/strong><\/a> \u2013 Assistant Professor of Medicine, General Internal Medicine and Infectious Diseases,\u00a0Boston University Chobanian & Avedisian School of Medicine<\/span><\/p>\n

Jeffrey Samet, MD, MA, MPH <\/strong><\/a> \u2013 Professor of Medicine, General Internal Medicine,\u00a0Boston University Chobanian & Avedisian School of Medicine<\/span><\/p>\n

Selected Publications<\/span><\/strong><\/h4>\n

Fisk-Hoffman RJ<\/strong>, Ranger S, Gracy A, Siuluta N, Parisi CE, Payton I, Cook RL, Canidate S. Recommendations for the Design and Implementation of Alcohol Pharmacotherapy Trials: Perspectives of Women With HIV Participating in the WHAT-IF Study<\/a>. J Addict Med. 2024 Nov 19. doi: 10.1097\/ADM.0000000000001410. Epub ahead of print. PMID: 39560292.<\/span><\/p>\n

Fisk-Hoffman RJ<\/strong>, Liu Y, Somboonwit C, Widmeyer M, Canidate S, Prosperi M, Cook RL. Who wants long-Acting injectable antiretroviral therapy? Treatment preferences among adults with HIV in Florida.<\/a> AIDS Care. 2024 Nov;36(11):1545-1554. doi: 10.1080\/09540121.2024.2383872. Epub 2024 Aug 1. PMID: 39088731; PMCID: PMC11511631.<\/span><\/p>\n

Fisk-Hoffman RJ<\/strong>, Ranger SS, Gracy A, Gracy H, Manavalan P, Widmeyer M, Leeman RF, Cook RL, Canidate S. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir\/Rilpivirine for Antiretroviral Therapy in Florida<\/a>. AIDS Patient Care STDS. 2024 Jun;38(6):275-285. doi: 10.1089\/apc.2024.0067. Epub 2024 Apr 30. PMID: 38686517; PMCID: PMC11301705.<\/span><\/p>\n

Rich SN, Liu Y, Fisk-Hoffman R<\/strong>, Zheng Y, Hu H, Spencer EE, Cook RL, Prosperi M. Spatial and temporal analysis of HIV clinical outcomes in Florida reveals counties with persistent racial and ethnic disparities during 2012-2019<\/a>. BMC Public Health. 2024 Mar 9;24(1):749. doi: 10.1186\/s12889-024-17944-w. PMID: 38459461; PMCID: PMC10924316.<\/span><\/p>\n

Fisk-Hoffman RJ<\/strong>, Parisi CE, Siuluta N, Ding DD, Widmeyer M, Somboonwit C, Cook RL. Antiretroviral Therapy Concealment Behaviors and their Association with Antiretroviral Therapy Adherence among People with HIV: Findings from the Florida Cohort Study<\/a>. AIDS Behav. 2024 Mar;28(3):1047-1057. doi: 10.1007\/s10461-023-04214-w. Epub 2023 Oct 20. PMID: 37861924; PMCID: PMC10922241.<\/span><\/p>\n

Josiane Fofana, PhD<\/strong><\/h2>\n

\"\"Josiane Fofana, PhD, earned her doctorate in Virology, Immunology, and Microbiology (VIM) from Boston University School of Medicine. During her training, she was awarded research support through the BU Immunology Training Program (T32) and a Ruth L. Kirschstein Predoctoral Individual National Research Service Award (F31). Prior to that, she received her B.S. in Biochemistry from Brandeis University.<\/p>\n

During her doctoral training, Josiane developed long-acting nanoparticle-based strategies to improve antiretroviral drug delivery to HIV tissue reservoirs. She subsequently completed the Fogarty Global Health Fellowship (LAUNCH program), which initiated her research in Ghana.<\/p>\n

As a BU-CHART fellow, Josiane is based at the Noguchi Memorial Institute for Medical Research, University of Ghana. Her research focuses on elucidating the mechanisms underlying insulin resistance in people living with HIV, with an emphasis on its role as an early marker of metabolic dysfunction. Her work bridges immunology, metabolism, and mitochondrial biology to better understand cardiometabolic risk in this population.<\/p>\n

Mentors<\/span><\/strong><\/h4>\n

Elijah Paintsil, PhD<\/strong><\/a> \u2013 Professor and Chair, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Andrew Henderson, PhD<\/strong><\/a>\u00a0\u2013 Professor Medicine and Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Jennifer Snyder-Cappione, PhD <\/strong><\/a>\u2013 Assistant Professor Medicine and Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/span><\/strong><\/h4>\n

Fofana J<\/strong>, Zahara S, Chan T, Zang H, Reinhard BM, Gummuluru S. Enhancing antiretroviral delivery to secondary lymph nodes by targeting CD169\u2009+\u2009macrophages with HIV-mimicking nanoparticles<\/a>. Sci Rep. 2025 Nov 25;15(1):45302. doi: 10.1038\/s41598-025-29002-5. PMID: 41291024; PMCID: PMC12748623.<\/span><\/p>\n

Eshaghi B, Fofana J<\/strong>, Nodder SB, Gummuluru S, Reinhard BM. Virus-Mimicking Polymer Nanoparticles Targeting CD169<\/a><\/span>+<\/sup>\u00a0Macrophages as Long-Acting Nanocarriers for Combination Antiretrovirals. ACS Appl Mater Interfaces. 2022 Jan 19;14(2):2488-2500. doi: 10.1021\/acsami.1c17415. Epub 2022 Jan 7. PMID: 34995059; PMCID: PMC9126061.<\/span><\/p>\n

Zang H, Fofana J<\/strong>, Xu F, Nodder SB, Gummuluru S, Reinhard BM. Characterizing Lipid-Coated Mesoporous Silica Nanoparticles as CD169-Binding Delivery System for Rilpivirine and Cabotegravir<\/a>. Adv Nanobiomed Res. 2022 May;2(5):2100157. doi: 10.1002\/anbr.202100157. Epub 2022 Mar 13. PMID: 36313942; PMCID: PMC9610980.<\/span><\/p>\n

Lars Howell, PhD<\/strong><\/h2>\n

\"\"<\/p>\n

Lars Howell, PhD received their PhD in Chemical Engineering from the University of Massachusetts Amherst. During their dissertation they engineered Salmonella typhimurium <\/em>to deliver antigen and adjuvant molecules to serve as novel cancer immunotherapies. They characterized the impact of engineered Salmonella on antigen presenting cell and T cell activation as well as the pharmacokinetics of the bacteria and impact on tumor growth. During their PhD, Lars was awarded the three-year Graduate Research Fellowship through the National Science Foundation.<\/p>\n

As a BU-CHART fellow, Lars will be developing novel in vitro <\/em>organoid systems to examine the immune response to HIV and Tuberculosis co-infection. They are also working on a project characterizing the impact of HIV sequence on genome integration site.<\/p>\n

Mentors<\/strong><\/span><\/h4>\n

Manish Sagar, MD<\/a> \u2013 <\/strong>Professor Medicine and Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Andrew Henderson, PhD<\/strong><\/a>\u00a0\u2013 Professor Medicine and Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Suryaram Gummuluru, PhD<\/a> \u2013 <\/strong>Professor and Vice Chair of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/u><\/strong><\/h4>\n

Howell LM<\/strong>, Manole S, Reitter AR, Forbes NS. Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer<\/a>. Microb Biotechnol. 2024 May;17(5):e14461. doi: 10.1111\/1751-7915.14461. PMID: 38758181; PMCID: PMC11100551.<\/span><\/p>\n

Howell LM<\/strong>, Forbes NS. Mathematical Modeling of\u00a0<\/a><\/span>Salmonella<\/i>\u00a0Cancer Therapies Demonstrates the Necessity of Both Bacterial Cytotoxicity and Immune Activation. Bioengineering (Basel). 2025 Jul 10;12(7):751. doi: 10.3390\/bioengineering12070751. PMID: 40722443; PMCID: PMC12293069.<\/span><\/p>\n

Raman V, Howell LM<\/strong>, Bloom SMK, Hall CL, Wetherby VE, Minter LM, Kulkarni AA, Forbes NS. Intracellular\u00a0<\/span>Salmonella<\/i><\/a>\u00a0delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity. Front Immunol. 2023 Oct 5;14:1228532. doi: 10.3389\/fimmu.2023.1228532. PMID: 37868996; PMCID: PMC10585021.<\/span><\/p>\n

Howell LM<\/strong>, Forbes NS. Bacteria-based immune therapies for cancer treatment<\/a>. Semin Cancer Biol. 2022 Nov;86(Pt 2):1163-1178. doi: 10.1016\/j.semcancer.2021.09.006. Epub 2021 Sep 20. PMID: 34547442.<\/span><\/p>\n

Samantha Malatesta, PhD<\/strong><\/h2>\n

\"\"Samantha Malatesta, PhD earned her PhD in Biostatistics from Boston University and her undergraduate degree in Statistics from North Carolina State University. Her PhD work focused on developing statistical methods to analyze data collected through respondent-driven sampling with applications to tuberculosis and HIV. She also developed a model to classify tuberculosis disease severity for persons initiating TB treatment that integrates multiple diagnostics.<\/p>\n

As a BU-CHART fellow, Sam will continue working with Dr. Laura White and Dr. Karen Jacobson and aims to contribute to statistical methods for understanding tuberculosis transmission that integrates whole genome sequencing data and individual-level clinical data. She is particularly interested in settings with both a high TB and HIV burden where community transmission is common. This project is motivated by her work with Dr. Jacobson\u2019s cohorts in South Africa that aim to understand tuberculosis disease burden and transmission among people who smoke drugs.<\/p>\n

Mentors<\/strong><\/span><\/h4>\n

Laura F. White, PhD<\/strong><\/a>\u2014 Professor of\u00a0 Biostatistics, Boston University School of Public Health<\/p>\n

Karen Jacobson, MD, MPH<\/a><\/strong>\u2014 Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/strong><\/span><\/h4>\n

Wijk M, Gausi K, Malatesta S<\/strong>, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs<\/a>. J Antimicrob Chemother. 2024 Aug 1;79(8):2022-2030. doi: 10.1093\/jac\/dkae206. PMID: 38985541; PMCID: PMC11290884.<\/span><\/p>\n

Myers B, Carney T, Rooney J, Malatesta S<\/strong>, Ragan EJ, White LF, Natcheva H, Bouton TC, Weber SE, Farhat M, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Smoked drug use in patients with TB is associated with higher bacterial burden<\/a>. Int J Tuberc Lung Dis. 2023 Jun 1;27(6):444-450. doi: 10.5588\/ijtld.22.0650. PMID: 37231597; PMCID: PMC10407961.<\/span><\/p>\n

Malatesta S<\/strong>, Weir IR, Weber SE, Bouton TC, Carney T, Theron D, Myers B, Horsburgh CR, Warren RM, Jacobson KR, White LF. Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation<\/a>. BMC Med Res Methodol. 2022 Nov 19;22(1):297. doi: 10.1186\/s12874-022-01782-8. PMID: 36402979; PMCID: PMC9675206.<\/span><\/p>\n

Myers B, Carney T, Rooney J, Malatesta S<\/strong>, White LF, Parry CDH, Bouton TC, Ragan EJ, Horsburgh CR Jr, Warren RM, Jacobson KR. Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa’s COVID-19 Sales Bans: A Case Series<\/a>. Int J Environ Res Public Health. 2021 May 19;18(10):5449. doi: 10.3390\/ijerph18105449. PMID: 34069737; PMCID: PMC8161406.<\/span><\/p>\n

Roshni Singh, MD<\/strong><\/h2>\n

\"\"Roshni Singh, MD earned her medical degree from Drexel University College of Medicine in 2020. She completed internal medicine residency and infectious diseases fellowship at Boston Medical Center. During her time in training, she developed an interest in viral hepatitis, health equity and HIV care in immigrant populations.<\/p>\n

As a BU-CHART fellow, Roshni will continue research on screening and treatment for viral hepatitis in people with or at-risk for HIV as well as linkage to care in these populations.<\/p>\n

<\/h4>\n

Mentors<\/strong><\/span><\/h4>\n

Rachel Epstein , MD, MScE<\/a> \u2013\u00a0<\/strong>Assistant Professor, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Benjamin Linas, MD<\/strong><\/a> \u2013 Professor, Boston University Chobanian & Avedisian School of Medicine<\/p>\n

Selected Publications<\/strong><\/span><\/h4>\n

Singh R., <\/strong>Biondi B, Gordon SH, Linas BP, Epstein RL. Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines.<\/a> JAMA. 2025 Apr 15;333(15):1356-1358. doi: 10.1001\/jama.2024.28774. PMID: 39992633; PMCID: PMC11851293.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Christopher Chiu, PhD, MA Christopher Chiu, PhD, MA received his PhD and MA in Clinical Psychology from the University of Massachusetts Boston and his undergraduate degree in Psychology from the University of Rochester. He was a predoctoral and postdoctoral fellow in the Behavioral Medicine program at the Massachusetts General Hospital\/Harvard Medical School. During his graduate […]<\/p>\n","protected":false},"author":15470,"featured_media":0,"parent":58,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/pages\/3450"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/users\/15470"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/comments?post=3450"}],"version-history":[{"count":50,"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/pages\/3450\/revisions"}],"predecessor-version":[{"id":6266,"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/pages\/3450\/revisions\/6266"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/pages\/58"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/id\/wp-json\/wp\/v2\/media?parent=3450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}